Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC9B1P3 encodes a pseudogene related to the solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1. Unlike functional SLC9B transporters (such as SLC9B1/NHA1 and SLC9B2/NHA2), which mediate sodium/proton exchange and are involved in ion homeostasis, SLC9B1P3 is not translated into a functional protein. Pseudogenes like SLC9B1P3 may arise by gene duplication or retrotransposition and often contain sequence similarity to their functional counterparts but lack protein-coding ability due to mutations, frame shifts, or absence of essential regulatory elements. There is no established biological function, disease association, or pharmacological interaction for SLC9B1P3. Its nomenclature is easily confusable with active transporter proteins, so care must be taken not to mistake this pseudogene for a protein-coding member (e.g., SLC9B1/NHA1)[7][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 9 member B1 pseudogene 3 (SLC9B1P3).